FILTER
FILTERED INTERVIEW RESULTS
Gaurav Kaushik
MD AND CEO, METEORIC BIOPHARMACEUTICALS
"We have witnessed growing interest in utilizing plant-derived enzymes across various applications."
Saurabh Gurnurkar
MANAGING DIRECTOR, UQUIFA GROUP
"We can now initiate projects in Budapest and conclude them at our larger-scale GMP facility in Spain and/or Mexico, offering to our customers an option for integrated project management for their programs."
Tom Sellig
CEO, ADARE PHARMA SOLUTIONS
"There are hundreds of firms out there offering very specific services, and this will ultimately lead to more consolidation within the industry."
Victor Swint
CEO, FORMULATED SOLUTIONS
"Rather than merely facilitating tech transfers, we aspire to lead the innovation charge for our clients."
Bart van Berkel
CEO, CURTEC
"Since the establishment of our facility in the US, we have felt the appreciation of the market in being able to have a local partner, especially in light of many companies trying to localize their supply chains."
John Patrick Oroho
PRESIDENT AND GENERAL MANAGER, RLDATIX LIFE SCIENCES
"RLDatix is a one-stop-shop offering comprehensive solutions to navigate critical operational and compliance challenges in the life sciences industry."
Roger Erickson
CEO AND FOUNDER, INTERBIOME
"We have large and growing volumes of missing diagnostics and therapeutics that never even go through the pharma pipeline, not to mention the growing number of neglected products languishing in the development pipeline."
Subodh Deshmukh and Ramesh Subramanian
CEO BIOLOGICS AND PRESIDENT DEVELOPMENT (SD) AND CCO (RS), ARAGEN LIFE SCIENCES
"We further strengthened our drug product service offerings by adding clinical capacity to drug product manufacturing."
Kristof De Smedt and Amardeep Chahal
GLOBAL BUSINESS UNIT DIRECTOR (KS) AND SENIOR VP MARKETING CORPORATE DEVELOPMENT (AC), COLD CHAIN TECHNOLOGIES (CCT)
"By focusing on performance, cost-effectiveness, compliance, sustainability, and visibility, we help our pharmaceutical customers achieve the optimal balance in their thermal packaging solutions."
Peter Schiemann
CEO, YMMUNOBIO
"We are dedicated to establishing proof of concept with our ADC targeting NPTXR."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
Latin America Petrochemicals and Chemicals 2024 - Digital Interactive
The Latin America Petrochemicals and Chemicals 2024 report, produced in alliance with APLA, explores the current state of these industries, the challenges they face, and the opportunities they offer.
The Latin America Petrochemicals and Chemicals 2024 report, produced in alliance with APLA, explores the current state of these industries, the challenges they face, and the opportunities they offer.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
